ReleaseWire Connect

The growth of medical tourism, demand for better quality healthcare delivery by growing aging population, and increase in chronic disease patient population is driving the increased adoption of IT solutions in the emerging markets. The Healthcare IT markets in emerging economies is expected to grow from $5.3 billion in 2010 to $10.9 billion in 2015, at an estimated CAGR of 15.3% from 2010 to 2015. The hardware segment dominates the healthcare IT market in emerging economies and is expected to be the fastest growing segment for the next 5-7 years.

Modest efficacy results and lingering safety concerns have meant that developers of obesity drugs have failed to convince regulators of their risk-benefit profiles. The continued escalation of safety requirements in the light of recent withdrawals might see another raft of discontinuations, as Datamonitor views the chances of the late-stage pipeline candidates expanding the obesity market as slim

The insulin antidiabetic pipeline can be split between small manufacturers, often targeting reformulations of existing insulin, and major manufacturers pursuing novel insulin analogs. Pipeline products will need to show improvements in the clinical safety/side-effect profile of insulins, as change in delivery method alone will not be enough to gain market share.

In 2010, Datamonitor estimates that there were 5.3 million orthopedic surgeries in the seven major markets. Due to the aging populations in the seven major markets, this number is projected to increase to approximately 6.6 million orthopedic surgeries in 2020.

Datamonitor’s Report “Epidemiology: Major Abdominal Surgery – A key risk factor for deep vein thrombosis and pulmonary embolism” is now available at ReportsnReports.com.

Sepsis has high mortality levels; however, only few therapeutic strategies exist. The Surviving Sepsis Campaign (SSC) has helped to increase global awareness, standardize patient care, and reduce levels of mortality for sepsis. Negative clinical trial data have dented the commercial performance of Eli Lilly’s Xigris, creating an opportunity for improved sepsis therapeutics.

Datamonitor’s Report “Case Study: HIV - Better differential pricing strategies are needed to ensure access to HIV drugs” is now available at ReportsnReports.com.

The report explores approaches to HTA, profiles HTA organizations in six countries (Australia, Canada, France, Germany, the UK, and the US) and examines how their results are used to inform pricing and reimbursement decisions. The focus is on pharmaceuticals, medical devices, and diagnostics and how the rapidly evolving HTA environment will influence future market access of these technologies.

Business Insights’s Report “The Women’s Health Market Outlook to 2016” is now available at ReportsnReports.com.